Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -279,659 | -143,588 | -73,671 | -135,747 | -60,716 |
| Depreciation Amortization | 37,827 | 1,189 | 1,227 | 790 | 654 |
| Income taxes - deferred | -6,631 | -28,338 | 0 | N/A | N/A |
| Accounts receivable | -22,198 | 33,384 | -393 | -33,823 | N/A |
| Other Working Capital | -99,069 | 36,018 | 4,005 | 186,732 | 2,941 |
| Other Operating Activity | 112,289 | 3,841 | 12,673 | 39,954 | 4,714 |
| Operating Cash Flow | $-257,441 | $-97,494 | $-56,159 | $57,906 | $-52,407 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 153,110 | 243,269 | 149,998 | N/A | N/A |
| PPE Investments | -6,655 | -1,606 | -1,622 | -2,662 | -414 |
| Net Acquisitions | N/A | 6,147 | N/A | N/A | N/A |
| Purchase Of Investment | 0 | -224,216 | -330,636 | -147,009 | -77,175 |
| Sale Of Investment | 64,721 | 13,000 | 5,000 | 162,376 | 63,901 |
| Investing Cash Flow | $211,176 | $36,594 | $-177,260 | $12,705 | $-13,688 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 77,668 | 0 | N/A | N/A | N/A |
| Debt Repayment | -15,000 | -19 | -5 | -20 | -7 |
| Common Stock Issued | 26,728 | 96,581 | 116,245 | 66,966 | 83,100 |
| Common Stock Repurchased | -426 | N/A | 0 | N/A | N/A |
| Financing Cash Flow | $88,970 | $96,562 | $116,240 | $66,946 | $83,093 |
| Beginning Cash Position | 107,099 | 71,437 | 188,616 | 51,059 | 32,780 |
| End Cash Position | 149,804 | 107,099 | 71,437 | 188,616 | 49,778 |
| Net Cash Flow | $42,705 | $35,662 | $-117,179 | $137,557 | $16,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | -257,441 | -97,494 | -56,159 | 57,906 | -52,407 |
| Capital Expenditure | -6,655 | -1,606 | -1,622 | -2,662 | -414 |
| Free Cash Flow | -264,096 | -99,100 | -57,781 | 55,244 | -52,821 |